| Nath Bio-Genes (India) Ltd | Industry : (FMCG) | |
|---|---|---|
|
BSE Code : 537291 |
NSE Symbol : NATHBIOGEN |
P/E(TTM) : 8.58 |
|
ISIN Demat : INE448G01010 |
Div & Yield% : 1.14 |
EPS(TTM) : 20.52 |
|
Book Value(₹) : 362.75 |
Market Cap(₹Cr) : 334.47 |
Face Value(₹) : 10.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 45.69 | 65.96 | 39.77 | 280.17 | 49.37 | 36.87 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 45.69 | 65.96 | 39.77 | 280.17 | 49.37 | 36.87 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 3.63 | 4.42 | 1.93 | 3.83 | 4.58 | 0.48 |
| Total Income | 49.33 | 70.38 | 41.71 | 284.00 | 53.95 | 37.35 |
| Total Expenditure | 39.08 | 57.13 | 32.58 | 241.27 | 46.20 | 29.36 |
| PBIDT | 10.25 | 13.26 | 9.12 | 42.73 | 7.75 | 7.99 |
| Interest | 2.94 | 4.18 | 3.30 | 2.89 | 1.10 | 3.37 |
| PBDT | 7.31 | 9.08 | 5.82 | 39.84 | 6.65 | 4.62 |
| Depreciation | 1.02 | 0.98 | 0.98 | 0.98 | 1.32 | 0.83 |
| Tax | 2.50 | 0.87 | 0.64 | 0.66 | 0.63 | 1.14 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 3.79 | 7.23 | 4.20 | 38.21 | 4.71 | 2.66 |
| Extra-ordinary Items | 0.76 | 2.40 | 0.00 | 2.06 | 0.54 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 3.03 | 4.83 | 4.20 | 36.15 | 4.17 | 2.66 |
| EPS (Unit Curr.) | 2.17 | 3.85 | 2.21 | 20.06 | 2.12 | 1.40 |
| EPS (Adj) (Unit Curr.) | 2.17 | 3.85 | 2.21 | 20.06 | 2.12 | 1.40 |
| Calculated EPS (Unit Curr.) | 1.99 | 3.80 | 2.21 | 20.10 | 2.48 | 1.40 |
| Calculated EPS (Adj) (Unit Curr.) | 1.99 | 3.80 | 2.21 | 20.10 | 2.48 | 1.40 |
| Calculated EPS (Ann.) (Unit Curr.) | 7.97 | 15.22 | 8.84 | 80.42 | 9.91 | 5.59 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 7.97 | 15.22 | 8.84 | 80.42 | 9.91 | 5.59 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 589.53 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 22.43 | 20.10 | 22.93 | 15.25 | 15.70 | 21.67 |
| PBDTM(%) | 16.00 | 13.77 | 14.63 | 14.22 | 13.47 | 12.53 |
| PATM(%) | 8.30 | 10.96 | 10.56 | 13.64 | 9.54 | 7.21 |
